Highridge Bets on 'Smart' Disposable GPS for Spine Surgery

WESTMINSTER, Colo. – April 09, 2026 – Highridge Medical, a global spine company, has finalized an exclusive U.S. distribution agreement that could significantly alter the landscape of spinal surgery. The deal with Waypoint Orthopedics grants Highridge the rights to the Waypoint GPS™ (Guided Pedicle System), a novel technology designed to make one of the most critical steps in spine fusion—pedicle screw placement—safer, more efficient, and free from harmful radiation.

This strategic partnership positions Highridge to challenge the market's incumbents, not with another multi-million-dollar robot, but with a clever, single-use disposable tool. The move signals a broader trend in medical technology toward simplifying complex procedures, reducing costs, and improving safety without the steep learning curves and capital investments associated with traditional navigation and robotic platforms.

A New Direction in Surgical Navigation

For years, the gold standard for improving accuracy in pedicle screw placement has involved either frequent exposure to X-ray radiation via fluoroscopy or the adoption of large, capital-intensive robotic and navigation systems from giants like Medtronic, Stryker, and Globus Medical. While effective, these solutions come with significant drawbacks, including radiation exposure for the entire surgical team, high upfront costs, large operating room footprints, and complex workflows.

The Waypoint GPS platform offers a fundamentally different approach. Described as a “smart bone awl,” the device is a single-use, disposable probe that looks and feels like the standard instruments surgeons already use. Its innovation lies in its proprietary color-sensing technology. As a surgeon advances the probe to create a pilot hole in the vertebral pedicle, the Waypoint GPS provides real-time, visual feedback, wirelessly displayed on a simple app. This allows the surgeon to instantly differentiate between the desired soft, cancellous bone and the hard, cortical bone that forms the pedicle wall. This immediate feedback is critical for preventing a cortical breach—a potential complication where the screw path exits the bone, risking nerve or spinal cord injury.

“Technology like Waypoint GPS, designed to improve surgical accuracy and limit radiation exposure, while respecting the surgical workflow, supports our mission to deliver intelligent, integrated solutions that improve surgical outcomes, streamline workflows, and support value-based care,” said Rebecca Whitney, CEO of Highridge Medical, in a statement announcing the deal.

The system received FDA 510(k) clearance in May 2023 for both open and minimally invasive procedures. Early clinical use and in-vivo studies have demonstrated its potential, with one of the first surgical uses reporting 100% accuracy across 10 pedicle navigations with zero breaches, all without the use of intraoperative radiation for guidance.

A Strategic Play to Disrupt the Market

Highridge Medical’s agreement is more than just a product line extension; it's a calculated move that aligns with its stated goal of doubling its R&D investment through a mix of internal development and external acquisitions. By securing the Waypoint GPS, Highridge sidesteps a direct, capital-heavy confrontation with robotics manufacturers and instead carves out a new niche in the market for enabling technologies.

The competitive advantage is clear: cost and simplicity. Hospitals and ambulatory surgery centers (ASCs) can adopt the Waypoint GPS without any capital equipment investment. This is a game-changer, especially for ASCs, which operate on leaner budgets and prioritize efficiency and rapid patient turnover. The technology provides advanced navigational capabilities on a per-procedure basis, democratizing access to safer surgical techniques that were previously the domain of large, well-funded hospitals.

“This partnership between Highridge and Waypoint is going to transform the way that the industry thinks about enabling technology,” stated Jeffrey F. O’Donnell, Jr., President and CEO of Waypoint Orthopedics. “We are proud of the incredible development work our team has put into making the Waypoint GPS reliable and easy to use. Highridge is perfectly positioned to bring Waypoint to the masses.”

This “smart disposable” model effectively unbundles navigation from the implant, making the Waypoint GPS a vendor-agnostic tool that can be used with any company's pedicle screws. This flexibility is highly attractive to providers looking to avoid vendor lock-in and maintain control over their supply chain.

Streamlining the Operating Room

Beyond the financial and strategic implications, the most immediate impact of the Waypoint GPS will be felt within the operating room itself. The system’s intuitive design is a key selling point. Because it mimics a standard pedicle probe, the learning curve for surgeons is minimal, drastically reducing the extensive training required for complex robotic systems.

The single-use nature of the device introduces significant operational efficiencies. It eliminates the time, labor, and cost associated with sterilizing and reprocessing reusable navigational instruments. This not only streamlines the workflow between procedures but also completely removes the risk of cross-contamination from improperly cleaned devices, enhancing patient safety.

By providing real-time, intra-body feedback, the technology reduces reliance on intraoperative imaging. This saves time that would otherwise be spent setting up, capturing, and interpreting X-ray images. For the surgical team, it means a dramatic reduction in cumulative radiation exposure over the course of their careers—a major occupational health concern. For the patient, it means a safer procedure with potentially shorter anesthesia times.

As Highridge Medical prepares for a planned launch later this year, the spine surgery community will be watching closely. The Waypoint GPS represents a powerful convergence of innovation, safety, and economic sense. Its success could prove that the future of surgical advancement lies not only in increasing complexity and automation but also in the intelligent simplification of essential tools.